# Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes Mellitus

> **NCT06010992** · PHASE2 · UNKNOWN · sponsor: **Tanta University** · enrollment: 70 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Nitazoxanide

## Key facts

- **NCT ID:** NCT06010992
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2024-10-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2023-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06010992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06010992, "Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06010992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*